Rhenman & Partners Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.8M | Sell |
90,000
-206,000
| -70% | -$19.7M | 0.96% | 44 |
|
|
2025
Q4 | $28.4M | Buy |
296,000
+91,000
| +44% | +$8.84M | 2.66% | 4 |
|
|
2025
Q3 | $19.5M | Buy |
205,000
+25,500
| +14% | +$2.34M | 2.16% | 13 |
|
|
2025
Q2 | $15.6M | Sell |
179,500
-75,500
| -30% | -$6.4M | 1.98% | 18 |
|
|
2025
Q1 | $22.9M | Sell |
255,000
-14,500
| -5% | -$1.3M | 2.63% | 11 |
|
|
2024
Q4 | $21.5M | Sell |
269,500
-98,500
| -27% | -$8.53M | 2.21% | 14 |
|
|
2024
Q3 | $33.1M | Buy |
368,000
+160,000
| +77% | +$13.5M | 2.69% | 8 |
|
|
2024
Q2 | $16.4M | Sell |
208,000
-117,000
| -36% | -$9.59M | 1.57% | 22 |
|
|
2024
Q1 | $28.3M | Sell |
325,000
-266,000
| -45% | -$22.7M | 2.68% | 12 |
|
|
2023
Q4 | $48.7M | Buy |
591,000
+216,000
| +58% | +$16.5M | 4.86% | 1 |
|
|
2023
Q3 | $29.4M | Buy |
375,000
+83,000
| +28% | +$6.95M | 3.17% | 6 |
|
|
2023
Q2 | $25.7M | Buy |
292,000
+57,000
| +24% | +$4.91M | 2.71% | 8 |
|
|
2023
Q1 | $18.6M | Sell |
235,000
-115,000
| -33% | -$9.37M | 2.04% | 20 |
|
|
2022
Q4 | $27.2M | Buy |
350,000
+110,000
| +46% | +$8.92M | 2.84% | 3 |
|
|
2022
Q3 | $21M | Buy |
240,000
+90,000
| +60% | +$8.09M | 2.2% | 16 |
|
|
2022
Q2 | $13.5M | Sell |
150,000
-10,000
| -6% | -$1.01M | 1.53% | 25 |
|
|
2022
Q1 | $17.8M | Sell |
160,000
-136,000
| -46% | -$14.4M | 1.75% | 20 |
|
|
2021
Q4 | $30.9M | Buy |
296,000
+23,000
| +8% | +$2.66M | 2.06% | 14 |
|
|
2021
Q3 | $34.2M | Hold |
273,000
| – | – | 2.4% | 10 |
|
|
2021
Q2 | $33.9M | Sell |
273,000
-62,000
| -19% | -$7.78M | 2.3% | 8 |
|
|
2021
Q1 | $39.6M | Buy |
335,000
+15,000
| +5% | +$1.76M | 2.76% | 6 |
|
|
2020
Q4 | $37.5M | Buy |
320,000
+99,220
| +45% | +$10.9M | 3.06% | 4 |
|
|
2020
Q3 | $22.9M | Buy |
220,780
+90,000
| +69% | +$9.04M | 2.04% | 17 |
|
|
2020
Q2 | $12M | Hold |
130,780
| – | – | 1.3% | 33 |
|
|
2020
Q1 | $11.8M | Buy |
130,780
+5,750
| +5% | +$612K | 1.65% | 23 |
|
|
2019
Q4 | $14.2M | Sell |
125,030
-60,188
| -32% | -$6.6M | 1.55% | 26 |
|
|
2019
Q3 | $20.1M | Buy |
185,218
+22,335
| +14% | +$2.33M | 2.52% | 9 |
|
|
2019
Q2 | $15.9M | Sell |
162,883
-5,959
| -4% | -$544K | 1.75% | 22 |
|
|
2019
Q1 | $15.4M | Sell |
168,842
-131,561
| -44% | -$11.8M | 1.8% | 21 |
|
|
2018
Q4 | $27.3M | Buy |
300,403
+50,529
| +20% | +$4.72M | 3.12% | 3 |
|
|
2018
Q3 | $24.6M | Sell |
249,874
-30,000
| -11% | -$2.77M | 2.46% | 8 |
|
|
2018
Q2 | $24M | Buy |
279,874
+68,591
| +32% | +$5.73M | 2.45% | 8 |
|
|
2018
Q1 | $16.9M | Buy |
211,283
+47,058
| +29% | +$3.88M | 2.09% | 17 |
|
|
2017
Q4 | $13.3M | Sell |
164,225
-49,890
| -23% | -$4M | 1.79% | 21 |
|
|
2017
Q3 | $16.7M | Buy |
214,115
+23,000
| +12% | +$1.91M | 2.13% | 13 |
|
|
2017
Q2 | $17M | Buy |
191,115
+10,000
| +6% | +$843K | 2.44% | 9 |
|
|
2017
Q1 | $14.6M | Sell |
181,115
-34,125
| -16% | -$2.67M | 2.31% | 8 |
|
|
2016
Q4 | $15.3M | Buy |
+215,240
| New | +$16.9M | 2.94% | 5 |
|
|
2016
Q3 | – | Sell |
-127,000
| Closed | -$11M | – | 114 |
|
|
2016
Q2 | $11M | Sell |
127,000
-10,000
| -7% | -$809K | 1.96% | 15 |
|
|
2016
Q1 | $10.3M | Sell |
137,000
-112,000
| -45% | -$8.44M | 2.04% | 12 |
|
|
2015
Q4 | $19.2M | Sell |
249,000
-16,000
| -6% | -$1.2M | 2.9% | 3 |
|
|
2015
Q3 | $17.7M | Buy |
265,000
+110,200
| +71% | +$8.12M | 2.83% | 3 |
|
|
2015
Q2 | $11.5M | Buy |
154,800
+85,800
| +124% | +$6.56M | 1.38% | 21 |
|
|
2015
Q1 | $5.38M | Buy |
69,000
+34,000
| +97% | +$2.58M | 0.91% | 41 |
|
|
2014
Q4 | $2.53M | Sell |
35,000
-98,800
| -74% | -$6.86M | 0.73% | 58 |
|
|
2014
Q3 | $6.87M | Buy |
+133,800
| New | +$8.51M | 2.01% | 9 |
|
|
2014
Q2 | – | Sell |
-39,429
| Closed | -$2.43M | – | 103 |
|
|
2014
Q1 | $2.43M | Sell |
39,429
-35,571
| -47% | -$2.07M | 0.73% | 50 |
|
|
2013
Q4 | $4.3M | Buy |
+75,000
| New | +$4.25M | 1.68% | 19 |
|
Other funds holding MDT
VCM
VPM
Rhenman & Partners Asset Management's MDT Position: Q1 2026 in Review
Rhenman & Partners Asset Management reduced its Medtronic (MDT) stake by 70% in Q1 2026, selling an estimated $19.7M and leaving 90,000 shares worth $7.8M. The position accounts for 0.96% of the portfolio, ranked #44.
Rhenman & Partners Asset Management first reported a position in MDT in Q4 2013 and has held it in 48 quarters since. The position peaked at $48.7M in Q4 2023. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Rhenman & Partners Asset Management held 90,000 shares of Medtronic worth $7.8M as of Q1 2026.
- Rhenman & Partners Asset Management sold 206,000 Medtronic shares in Q1 2026, an estimated $19.7M.
- Medtronic made up 0.96% of Rhenman & Partners Asset Management's portfolio in Q1 2026, its #44 holding.
- Rhenman & Partners Asset Management first reported a position in Medtronic in Q4 2013 and has held it in 48 quarters since.
- Rhenman & Partners Asset Management's Medtronic position peaked at $48.7M in Q4 2023.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Rhenman & Partners Asset Management's 13F filing for Q1 2026, filed 14 May 2026.